2006Journal of Clinical Emergency CallRequires access

Investigation the Integrative Therapy Effect of Ambroxol in Patients with Acute Respiratory Distress Syndrome

Xiaowei Xiang

Open publisher page 0 citations

Abstract

Objective To investigate the integrative therapy effect of ambroxol which used as continu intravenous pump or intravenous dripping in patients with acute respiratory distress syndrome(ARDS).Methods 63 patients with ARDS were divided randomly into three groups,control group (group A,n=20) and treatment group(group B,n=21),(group C,n=22).Patients in group A were treated with 0.9% NaCl (200 ml),group B with ambroxol (60 mg) plus 0.9 % NaCl (200 ml) intrvenous dripping once a day for 7 days and group C with ambroxol (60 mg) plas 0.9 % NaCl (200 mg) continue pump 24 hours for 7 days.The plasma concentrations of IL-6,IL-8 were measured and blond gas analysis and pulmonary function index were taken before and after the infusion of 5 days and 7 days respectively.Re- sults Compared to group A and group B after treatment with ambroxol in group C,concentrations of IL-6,IL-8,blood gas analysis and pul- monary function index were improved significantly (P0.05 or P0.01).After treatment with ambroxol 7 day in group B,concentrations of IL-6,IL-8 were decresed distinctively(P0.05) compared to before treatment.In group A blood gas analysis and pulmonary function in- dex were much better than those before treatment and in group A(P0.05 or P0.01).Although blood gas analysis improved significant- ly (P0.05),concentrations of IL-6,IL-8 and pulmonary function index hadn't significantly change in group A (P0.05).Conclusion Ambroxol could restrain release of inflammatory media,decrease ALI and improve pulmonary function of patient with ARDS.Continue in- travenous pump is better than intravenous dripping

About this research paper

What this paper is about

Objective To investigate the integrative therapy effect of ambroxol which used as continu intravenous pump or intravenous dripping in patients with acute respiratory distress syndrome(ARDS).Methods 63 patients with ARDS were divided randomly into three groups,control group (group A,n=20) and treatment group(group B,n=21),(group C,n=22).Patients in group A were treated with 0.9% NaCl (200 ml),group B with ambroxol (60 mg) plus 0.9 % NaCl (200 ml) intrvenous dripping once a day for 7 days and group C with ambroxol (60 mg) plas 0.9 % NaCl (200 mg) continue pump 24 hours for 7 days.The plasma concentrations of IL-6,IL-8 were measured and blond gas analysis and pulmonary function index were taken before and after the infusion of 5 days and 7 days respectively.Re- sults Compared to group A and group B after treatment with ambroxol in group C,concentrations of IL-6,IL-8,blood gas analysis and pul- monary function index were improved significantly (P0.05 or P0.01).After treatment with ambroxol 7 day in group B,concentrations of IL-6,IL-8 were decresed distinctively(P0.05) compared to before treatment.In group A blood gas analysis and pulmonary function in- dex were much better than those before treatment and in group A(P0.05 or P0.01).Although blood gas analysis improved significant- ly (P0.05),concentrations of IL-6,IL-8 and pulmonary function index hadn't significantly change in group A (P0.05).Conclusion Ambroxol could restrain release of inflammatory media,decrease ALI and improve pulmonary function of patient with ARDS.Continue in- travenous pump is better than intravenous dripping

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the integrative therapy effect of ambroxol which used as continu intravenous pump or intravenous dripping in patients with acute respiratory distress syndrome(ARDS).Methods 63 patients with ARDS were divided randomly into three groups,control group (group A,n=20) and treatment group(group B,n=21),(group C,n=22).Patients in group A were treated with 0.9% NaCl (200 ml),group B with ambroxol (60 mg) plus 0.9 % NaCl (200 ml) intrvenous dripping once a day for 7 days and group C with ambroxol (60 mg) plas 0.9 % NaCl (200 mg) continue pump 24 hours for 7 days.The plasma concentrations of IL-6,IL-8 were measured and blond gas analysis and pulmonary function index were taken before and after the infusion of 5 days and 7 days respectively.Re- sults Compared to group A and group B after treatment with ambroxol in group C,concentrations of IL-6,IL-8,blood gas analysis and pul- monary function index were improved significantly (P0.05 or P0.01).After treatment with ambroxol 7 day in group B,concentrations of IL-6,IL-8 were decresed distinctively(P0.05) compared to before treatment.In group A blood gas analysis and pulmonary function in- dex were much better than those before treatment and in group A(P0.05 or P0.01).Although blood gas analysis improved significant- ly (P0.05),concentrations of IL-6,IL-8 and pulmonary function index hadn't significantly change in group A (P0.05).Conclusion Ambroxol could restrain release of inflammatory media,decrease ALI and improve pulmonary function of patient with ARDS.Continue in- travenous pump is better than intravenous dripping

Key concepts: Ambroxol, ARDS, Medicine, Group A, Acute respiratory distress, Group B, Arterial blood gas analysis, Blood gas analysis

Related papers

Back to paper searchBrowse research topicsOriginal source
Investigation the Integrative Therapy Effect of Ambroxol in Patients with Acute Respiratory Distress Syndrome — Research Paper | ScholarLens